ライフサイエンスコーパス: fibroblast growth factor receptor

1 tion of proteins and signal transduction via fibroblast growth-factor receptor.

2 rmal growth factor receptor, Ins-Ralpha, and fibroblast growth factor receptors.

3 changes associated with focal adhesions and fibroblast growth factor receptors.

4 RBB2 and ERBB3; and trace phosphorylation of fibroblast growth factor receptors.

5 ition of EGFRs but not by the stimulation of fibroblast growth factor receptors.

6 rrelations of diseases caused by variants in Fibroblast Growth Factor Receptor 1 ( FGFR1) and report

7 f Drosophila Torso (alpha(Tor)) or the mouse fibroblast growth factor receptor 1 (alpha(FR)).

8 revious studies have individually implicated fibroblast growth factor receptor 1 (FGFR1) and canonica

9 Recently, we found that mice lacking fibroblast growth factor receptor 1 (Fgfr1) and Fgfr2 (K

10 Expression of the gene encoding fibroblast growth factor receptor 1 (FGFR1) and subseque

11 post-implantation lethality associated with fibroblast growth factor receptor 1 (FGFR1) deficiency,

12 L in cell motility control via regulation of fibroblast growth factor receptor 1 (FGFR1) endocytosis.

13 These cells require the fibroblast growth factor receptor 1 (Fgfr1) gene for the

14 on and differentiation via expression of the fibroblast growth factor receptor 1 (FGFR1) gene is posi

15 atively spliced alpha-exon of the endogenous fibroblast growth factor receptor 1 (FGFR1) gene, which

16 Previous studies have implicated fibroblast growth factor receptor 1 (FGFR1) in limb deve

17 Fibroblast growth factor receptor 1 (FGFR1) is a transme

18 The fibroblast growth factor receptor 1 (FGFR1) is ectopical

19 Fibroblast growth factor receptor 1 (Fgfr1) is expressed

20 Fibroblast growth factor receptor 1 (FGFR1) is frequentl

21 Fibroblast growth factor receptor 1 (FGFR1) is the predo

22 Amplification of fibroblast growth factor receptor 1 (FGFR1) occurs in ap

23 CRISPR/Cas9-mediated deletion of fibroblast growth factor receptor 1 (FGFR1) or pretreatm

24 Fibroblast growth factor receptor 1 (Fgfr1) plays pleiot

25 lpha-exon by alternative RNA splicing of the fibroblast growth factor receptor 1 (FGFR1) primary tran

26 Activated fibroblast growth factor receptor 1 (FGFR1) propagates F

27 d growth factor receptor alpha (PDGFRA), and fibroblast growth factor receptor 1 (FGFR1) to cell prol

28 tivated with other tyrosine kinases, such as fibroblast growth factor receptor 1 (FGFR1), concomitant

29 nescence resonance energy transfer analysis, fibroblast growth factor receptor 1 (FGFR1)-5-hydroxytry

30 express a wide range of receptors, including fibroblast growth factor receptor 1 (FGFR1).

31 mal growth factor receptor (HEGFR) and human fibroblast growth factor receptor 1 (HFGFR1) mRNAs in th

32 hypothalamic amenorrhea: two variants in the fibroblast growth factor receptor 1 gene FGFR1 (G260E an

33 Inhibition of fibroblast growth factor receptor 1 in Tsc1-null mice su

34 et-derived growth factor receptor beta and a fibroblast growth factor receptor 1 kinase inhibitor) an

35 cible transcript-3.0 (wit3.0), also known as fibroblast growth factor receptor 1 oncogene partner 2 (

36 Fgfr1 (fibroblast growth factor receptor 1) was identified as a

37 as inhibited the mitogenic activity of both fibroblast growth factor receptor 1-expressing BaF3 cell

38 elial growth factor receptor 2 (VEGFR-2) and fibroblast growth factor receptor 1.

39 n-activated protein kinase and overexpressed fibroblast growth factor receptor 1.

40 thelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet

41 the second half of Ig-like domain 3 (D3) of fibroblast growth factor receptors 1-3 (FGFR1 to -3) gen

42 Activating mutations in the genes for fibroblast growth factor receptors 1-3 (FGFR1-3) are res

43 s of hypertrophy, including type X collagen, fibroblast growth factor receptors 1-3, parathyroid horm

44 Conditional derivatives of both fibroblast growth factor receptor-1 (F36VFGFR1) and the

45 owever, DNA synthesis and phosphorylation of fibroblast growth factor receptor-1 (FGFR-1) induced by

46 contrast, hypoxic mice carrying a disrupted fibroblast growth factor receptor-1 (Fgfr1) gene in GFAP

47 In integrative nuclear fibroblast growth factor receptor-1 (FGFR1) signaling a

48 A mouse model of human ZNF198-fibroblast growth factor receptor-1 (FGFR1) stem cell le

49 on-cleavage screen, including Hsp70, Notch1, fibroblast growth factor receptor-1 (FGFR1), poly-A-bind

50 ell-surface proteins cytokeratin-7 (CK7) and fibroblast growth factor receptor-1 (FGFR1), which are t

51 combined with the cytoplasmic domain of the fibroblast growth factor receptor-1 (FGFR1).

52 , we discovered that activation of inducible fibroblast growth factor receptor-1 (iFGFR1) in the mamm

53 vitro, this differentiation was inhibited by fibroblast growth factor receptor-1 Ab, demonstrating a

54 r-1 Ab, demonstrating a role of the CD56 and fibroblast growth factor receptor-1 interaction in this

55 lar endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 that are two key gro

56 ss in self-renewal occurs via alterations in fibroblast growth factor receptor-1, p38alpha and p38bet

57 lar endothelial growth factor receptor-2 and fibroblast growth factor receptor-1.

58 volves fibroblast growth factor-2 as well as fibroblast growth factor receptor-1.

59 Conditional ablation of Fibroblast Growth Factor receptors-1 and -2 (FGFR1/2) in

60 Fgf23 mRNA in bones and fibroblast growth factor receptors 1c and 3c and Klotho

61 Splicing of fibroblast growth factor receptor 2 (FGFR2) alternative

62 Mutations in fibroblast growth factor receptor 2 (FGFR2) and its liga

63 single nucleotide polymorphisms (SNP) within fibroblast growth factor receptor 2 (FGFR2) as one of th

64 Pax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in r

65 Activating mutations in fibroblast growth factor receptor 2 (FGFR2) cause severa

66 report that mice lacking the IIIb isoform of fibroblast growth factor receptor 2 (Fgfr2) exhibit seve

67 Mutually exclusive splicing of fibroblast growth factor receptor 2 (FGFR2) exons IIIb a

68 The fibroblast growth factor receptor 2 (FGFR2) gene exons I

69 ntify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 (FGFR2) gene in sper

70 Alternative splice variants of fibroblast growth factor receptor 2 (FGFR2) IIIb, design

71 have recently shown activating mutations in fibroblast growth factor receptor 2 (FGFR2) in 16% of en

72 etic evidence that En1 functions upstream of fibroblast growth factor receptor 2 (Fgfr2) in regulatin

73 Mice with conditional deletion of fibroblast growth factor receptor 2 (Fgfr2) in the urete

74 Fibroblast growth factor receptor 2 (FGFR2) is a crucial

75 on of epithelial and mesenchymal isoforms of Fibroblast Growth Factor Receptor 2 (FGFR2) is achieved

76 The ligand specificity of fibroblast growth factor receptor 2 (FGFR2) is determine

77 The regulatory mechanism of one such RTK, fibroblast growth factor receptor 2 (FGFR2) kinase, is s

78 The fibroblast growth factor receptor 2 (FGFR2) locus has be

79 e recognition sites such as exon IIIb of the fibroblast growth factor receptor 2 (FGFR2) mRNA.

80 ome (ABS), which has also been attributed to fibroblast growth factor receptor 2 (FGFR2) mutations.

81 Fibroblast growth factor receptor 2 (FGFR2) promotes ost

82 or receptor-bound protein 2 (Grb2), controls fibroblast growth factor receptor 2 (FGFR2) signaling by

83 In epithelial cells, alternative splicing of fibroblast growth factor receptor 2 (FGFR2) transcripts

84 Alternative splicing of fibroblast growth factor receptor 2 (FGFR2) transcripts

85 Previous studies demonstrate fibroblast growth factor receptor 2 (FGFR2) triggers Nan

86 Here, we show that somatic mutations of the fibroblast growth factor receptor 2 (FGFR2) tyrosine kin

87 In a panel of gastric cancer cell lines, fibroblast growth factor receptor 2 (FGFR2) was overexpr

88 g from activating or neomorphic mutations in fibroblast growth factor receptor 2 (FGFR2), underscore

89 s of Pten deletion, we deleted one allele of fibroblast growth factor receptor 2 (FGFR2).

90 otype associated with syndromic mutations in fibroblast growth factor receptor 2 (Fgfr2).

91 ding to amino acid changes S252W or P253R in fibroblast growth factor receptor 2 (FGFR2).

92 cgamma1 compete for the same binding site on fibroblast growth factor receptor 2 (FGFR2).

93 ffected individuals have a S252W mutation in fibroblast growth factor receptor 2 (FGFR2).

94 The epithelial isoform of fibroblast growth factor receptor 2 (Fgfr2b) is essentia

95 hnRNP F proteins as being novel silencers of fibroblast growth factor receptor 2 exon IIIc.

96 SNPs in the fibroblast growth factor receptor 2 gene (FGFR2) and the

97 s to study renal development in mice lacking fibroblast growth factor receptor 2 in the ureteric bud

98 n breast cancer prevention, and suggest that fibroblast growth factor receptor 2 signalling has an im

99 XA1, GATA3 and PTTG1 as master regulators of fibroblast growth factor receptor 2 signalling, and show

100 and show that ERalpha occupancy responds to fibroblast growth factor receptor 2 signalling.

101 In addition, FGFR2 (fibroblast growth factor receptor 2) depletion in HSulf-

102 thelial growth factor receptor 2, TIE-2, and fibroblast growth factor receptor 2).

103 es expression of bone morphogenic protein 7, fibroblast growth factor receptor 2, insulin-like growth

104 Methylation at fibroblast growth factor receptor 2, methionine adenosyl

105 The fibroblast growth factor receptor 2-IIIb (FGFR2b) and th

106 Alternative splicing of fibroblast growth factor receptor-2 (FGFR2) mutually exc

107 FR-2, showed very modest selectivity against fibroblast growth factor receptor-2 (IC(50) = 0.21 micro

108 suggested that FGF10, acting mainly through fibroblast growth factor receptor 2b (FGFR2b), is crucia

109 lacks a Src-binding site, using shedding of fibroblast growth factor receptor 2iiib variant as an as

110 an autosomal-dominant activating mutation in fibroblast growth factor receptor 3 (FGFR3(P250R) ).

111 ice with the K644E kinase domain mutation in fibroblast growth factor receptor 3 (Fgfr3) (EIIa;Fgfr3(

112 have the same point mutation in the gene for fibroblast growth factor receptor 3 (FGFR3) and more tha

113 n that it involves 2 potential target genes: fibroblast growth factor receptor 3 (FGFR3) and multiple

114 Mutations to fibroblast growth factor receptor 3 (FGFR3) and phosphat

115 athymic nude mice, due to down regulation of fibroblast growth factor receptor 3 (FGFR3) and PI3K/Akt

116 Although activating mutations of fibroblast growth factor receptor 3 (FGFR3) are frequent

117 Mutations of fibroblast growth factor receptor 3 (FGFR3) are responsi

118 Ectopic expression of fibroblast growth factor receptor 3 (FGFR3) associated w

119 Fibroblast growth factor receptor 3 (FGFR3) belongs to a

120 have previously shown that dysregulation of fibroblast growth factor receptor 3 (FGFR3) by the t(4;1

121 Mutations in fibroblast growth factor receptor 3 (FGFR3) cause the mo

122 380R mutation in the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) causes achon

123 Fibroblast growth factor receptor 3 (FGFR3) coimmunoprec

124 ently reported that receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) directly tyr

125 Recently, fibroblast growth factor receptor 3 (FGFR3) has also bee

126 380R mutation in the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) in >97% of t

127 We recently found that the fibroblast growth factor receptor 3 (FGFR3) interacts wi

128 Fibroblast growth factor receptor 3 (FGFR3) is a key reg

129 Fibroblast growth factor receptor 3 (FGFR3) is a major n

130 Fibroblast growth factor receptor 3 (FGFR3) is a recepto

131 Ectopic activation of fibroblast growth factor receptor 3 (FGFR3) is associate

132 Fibroblast growth factor receptor 3 (FGFR3) is expressed

133 ly, we found that the enhanced activation of fibroblast growth factor receptor 3 (FGFR3) is linked to

134 The A391E mutation in fibroblast growth factor receptor 3 (FGFR3) is the genet

135 Fibroblast growth factor receptor 3 (FGFR3) mutations ar

136 Missense mutations of fibroblast growth factor receptor 3 (FGFR3) occur in up

137 Gly380 --> Arg mutation in the TM domain of fibroblast growth factor receptor 3 (FGFR3) of the RTK f

138 Fibroblast growth factor receptor 3 (FGFR3) plays a crit

139 ysregulation of the receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) plays a path

140 Fibroblast growth factor receptor 3 (FGFR3) plays an imp

141 Aberrant fibroblast growth factor receptor 3 (FGFR3) signaling di

142 Research on the mutation in Fibroblast Growth Factor Receptor 3 (FGFR3) that causes

143 is associated with ectopic overexpression of fibroblast growth factor receptor 3 (FGFR3) that sometim

144 y of dimer formation of the G380R mutants of fibroblast growth factor receptor 3 (FGFR3) transmembran

145 for heterodimer formation between wild-type fibroblast growth factor receptor 3 (FGFR3) transmembran

146 hogenic mutations (V664E in Neu and A391E in fibroblast growth factor receptor 3 (FGFR3)) on receptor

147 Activating mutations within fibroblast growth factor receptor 3 (FGFR3), a receptor

148 Activating mutations within fibroblast growth factor receptor 3 (FGFR3), a receptor

149 ons that exaggerate the signal output of the fibroblast growth factor receptor 3 (FGFR3), a receptor

150 estigated whether the TM domains of one RTK, fibroblast growth factor receptor 3 (FGFR3), dimerize in

151 nic mutation is the Ala391-->Glu mutation in fibroblast growth factor receptor 3 (FGFR3), linked to C

152 erozygous Pro250Arg substitution mutation in fibroblast growth factor receptor 3 (FGFR3), which incre

153 is caused by a gain-of function mutation in fibroblast growth factor receptor 3 (FGFR3).

154 inomas contain activating point mutations of fibroblast growth factor receptor 3 (FGFR3).

155 titution of an amino acid with a cysteine in fibroblast growth factor receptor 3 (FGFR3).

156 tions on dimerization of TM domains of human fibroblast growth factor receptor 3 (FGFR3).

157 rmation induced by the constitutively active fibroblast growth factor receptor 3 (K/E-FR3) (Oncogene,

158 g 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (fibroblast growth factor receptor 3 [FGFR3] and multiple

159 E TM domain mutation on the stability of the fibroblast growth factor receptor 3 dimer in the presenc

160 these results to the case of the isolated TM fibroblast growth factor receptor 3 domains.

161 ge and the frequencies of sperm with DFI and fibroblast growth factor receptor 3 gene (FGFR3) mutatio

162 ude HER2, epidermal growth factor receptors, fibroblast growth factor receptor 3, mTOR and others.

163 caused by gain-of-function mutations in the fibroblast growth factor receptor 3-encoding (FGFR3-enco

164 ctivity, including: CHIR-258, which inhibits fibroblast growth factor receptor 3; NVP-ADW742, which i

165 lasia or achondroplasia, in the TM domain of fibroblast growth factor receptors 3 (FGFR3).

166 rm of human achondrodysplasia, linked to the fibroblast-growth-factor receptor 3 locus, not linked to

167 sia caused by a gain-of-function mutation in fibroblast-growth-factor-receptor 3 (FGFR3).

168 Fibroblast growth factor receptor-3 (FGFR-3) expression

169 thelial cells, secretoneurin also stimulated fibroblast growth factor receptor-3 and insulin-like gro

170 receptor, bone morphogenetic protein-7, and fibroblast growth factor receptor-3 expression increased

171 observed stimulation of VEGF receptor-1 and fibroblast growth factor receptor-3.

172 mulates further growth factor receptors like fibroblast growth factor receptor-3.

173 vascular endothelial growth factor (VEGF) or fibroblast growth factor receptor-3.

174 l approach involving antisense inhibition of fibroblast growth factor receptor 4 (FGFR4) in periphera

175 The role of fibroblast growth factor receptor 4 (FGFR4) in regulatin

176 KLB rs17618244 with 3 nonsynonymous SNPs of fibroblast growth factor receptor 4 (FGFR4) revealed tha

177 ocal acetylcholine release, synergizing with fibroblast growth factor receptor activation to increase

178 Y240 phosphorylation can be mediated by both fibroblast growth factor receptors and SRC family kinase

179 ing platelet-derived growth factor receptor, fibroblast growth factor receptor, and Met, leading to i

180 Mutations in fibroblast growth factor receptors are known as the gene

181 t to a LOX-PP target at or near the level of fibroblast growth factor receptor binding or activation.

182 epithelial growth factor receptor (EGFR) and fibroblast growth factor receptor/breathless (FGFR, Btl)

183 transition promoted by the oncogenic Met and fibroblast growth factor receptors, but not by progester

184 the Notch ligands Jagged1 and Delta1 induced fibroblast growth factor receptor-dependent cell transfo

185 growth factor-A (PDGF-A), dominant-negative fibroblast growth factor receptor (DN-FGFR), or DN-Sprou

186 Signaling by the Caenorhabditis elegans fibroblast growth factor receptor EGL-15 is activated by

187 f both populations, whereas argonaute2 and a fibroblast growth factor receptor-encoding gene are requ

188 Interestingly, FAK knockdown did not modify fibroblast growth factor receptor expression induced by

189 p11;q12) results in expression of the ZNF198-fibroblast growth factor receptor (FGFR) 1 fusion tyrosi

190 oncogenes including erbB-2/HER-2, C-MYC, and fibroblast growth factor receptor (FGFR) 2.

191 iency results in cell-autonomous loss of the fibroblast growth factor receptor (Fgfr) 2b, which is re

192 ithelial cells resulted in a higher level of fibroblast growth factor receptor (FGFR) activation and

193 to mediate cell repulsion is antagonized by fibroblast growth factor receptor (FGFR) activation that

194 Levels of fibroblast growth factor receptor (FGFR) and cSrc were 4

195 athway analysis of these 69 genes implicated fibroblast growth factor receptor (FGFR) as a key regula

196 F3 cell line expresses only a single type of fibroblast growth factor receptor (FGFR) but produces ne

197 Activation of the fibroblast growth factor receptor (FGFR) by neural cell

198 The current working model for fibroblast growth factor receptor (FGFR) dimerization an

199 n of Frs2alpha (Six2creFrs2alphaKO), a major fibroblast growth factor receptor (Fgfr) docking protein

200 esses paralleled the dorsoventral changes in fibroblast growth factor receptor (FGFR) expressions.

201 The prototypical fibroblast growth factor receptor (FGFR) extracellular d

202 ivation specific for the PTKs in the Src and fibroblast growth factor receptor (FGFR) families, key e

203 FGFRL1 is a newly identified member of the fibroblast growth factor receptor (FGFR) family expresse

204 The fibroblast growth factor receptor (FGFR) family of recep

205 c pathways mediated by the VEGFR family, the fibroblast growth factor receptor (FGFR) family, the pla

206 red receptor tyrosine kinase families is the fibroblast growth factor receptor (FGFR) family, with am

207 Fgf ligands and heparin, is a member of the fibroblast growth factor receptor (Fgfr) family.

208 Fibroblast growth factor receptor (FGFR) gene products (

209 -frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or

210 The expression of the fibroblast growth factor receptor (FGFR) heartless and i

211 Here, we show that the selective fibroblast growth factor receptor (FGFR) inhibitor PD173

212 s, an effect abolished by treatment with the fibroblast growth factor receptor (FGFR) inhibitor SU540

213 e rates have been low for biomarker-directed fibroblast growth factor receptor (FGFR) inhibitor thera

214 ng mutation, and the combination of EGFR and fibroblast growth factor receptor (FGFR) inhibitors was

215 Epidermal Growth Factor Receptor (EGFR) and Fibroblast Growth Factor Receptor (FGFR) is required for

216 e the dimer stabilities of three full-length fibroblast growth factor receptor (FGFR) mutants harbori

217 identified cross-talk between the Hippo and fibroblast growth factor receptor (FGFR) oncogenic signa

218 d enhanced Ihh and Pthrp expression, whereas fibroblast growth factor receptor (FGFR) or mitogen-acti

219 nto the eye field, whereas activation of the fibroblast growth factor receptor (FGFR) represses these

220 Fibroblast growth factor receptor (FGFR) signaling deter

221 tivating activity, controls ERK1/2-dependent fibroblast growth factor receptor (FGFR) signaling in ch

222 Here, we aim to determine if 1) FGF-2/fibroblast growth factor receptor (FGFR) signaling is su

223 Aberrant activations of the Notch and fibroblast growth factor receptor (FGFR) signaling pathw

224 ce that this alternative pathway may involve fibroblast growth factor receptor (FGFR) signaling.

225 n fibroblasts, RCC broadly induced low-level fibroblast growth factor receptor (FGFR) signaling.

226 HNSCC) cell lines exhibit dominant autocrine fibroblast growth factor receptor (FGFR) signaling.

227 n substrate for two proteins involved in the fibroblast growth factor receptor (FGFR) signalling path

228 th factor receptor (KGFR) is a member of the fibroblast growth factor receptor (FGFR) superfamily.

229 for the work described here, we selected the fibroblast growth factor receptor (FGFR) tyrosine kinase

230 JNJ-42756493 is an orally administered pan-fibroblast growth factor receptor (FGFR) tyrosine kinase

231 N-cadherin caused fibroblast growth factor receptor (FGFR) upmodulation, r

232 We show here that the C. elegans fibroblast growth factor receptor (FGFR), EGL-15, affect

233 The Caenorhabditis elegans fibroblast growth factor receptor (FGFR), EGL-15, regula

234 ), insulin growth factor 2 receptor (IGF2R), fibroblast growth factor receptor (FGFR), etc.

235 ed significant inhibitory activities against fibroblast growth factor receptor (FGFR), platelet-deriv

236 of diverse transmembrane receptors including fibroblast growth factor receptor (FGFR), platelet-deriv

237 The expression of fibroblast growth factor receptor (FGFR)-1 correlates wi

238 en induced cell growth, MM134 cells required fibroblast growth factor receptor (FGFR)-1 signaling to

239 or (A(2A)R) and the receptor tyrosine kinase fibroblast growth factor receptor (FGFR).

240 on of Frizzled (Fz) serpentine receptors and fibroblast growth factor receptor (FGFR).

241 activation mechanism of the kinase domain of Fibroblast Growth Factor Receptor (FGFR).

242 Fibroblast growth factor receptors (Fgfr) comprise a wid

243 Aberrant activation of fibroblast growth factor receptors (FGFR) contributes to

244 Fibroblast growth factor receptors (FGFR) play key roles

245 study the hetero-interactions between three fibroblast growth factor receptors-FGFR1, FGFR2, and FGF

246 The fibroblast growth factor receptor FGFR2 is overexpressed

247 ct gain-of-function mutations in five genes (fibroblast growth factor receptors FGFR2 and FGFR3, tyro

248 th factor receptor alpha (PDGFRA) and type 3 fibroblast growth factor receptor (FGFR3), receptor tyro

249 Activation of the fibroblast growth factor receptor FGFR4 by FGF19 drives

250 rs351855) in the transmembrane domain of the fibroblast growth factor receptor (FGFR4) is associated

251 Conditional deletion of fibroblast growth factor receptors (Fgfrs) 1 and 2 in th

252 To determine the importance of fibroblast growth factor receptors (fgfrs) 1 and 2 in th

253 Mutations in fibroblast growth factor receptors (Fgfrs) 1-3 cause ske

254 Endothelial cells (ECs) express fibroblast growth factor receptors (FGFRs) and are exqui

255 ingly, Prox1 also controls the expression of fibroblast growth factor receptors (FGFRs) and can bind

256 Fibroblast growth factor receptors (FGFRs) are a family

257 Fibroblast growth factor receptors (FGFRs) are activated

258 Fibroblast growth factor receptors (FGFRs) are frequentl

259 Fibroblast growth factor receptors (FGFRs) are involved

260 We show here that in mouse embryos, Fibroblast growth factor receptors (FGFRs) are required

261 Fibroblast growth factor receptors (FGFRs) can act as dr

262 Mutations in fibroblast growth factor receptors (FGFRs) cause human b

263 We show that loss of function of all fibroblast growth factor receptors (FgfRs) expressed at

264 Somatic alterations of fibroblast growth factor receptors (FGFRs) have been des

265 To understand the role of specific fibroblast growth factor receptors (FGFRs) in cortical d

266 Signaling through fibroblast growth factor receptors (FGFRs) is essential

267 Fibroblast growth factor receptors (FGFRs) play key role

268 The family of fibroblast growth factor receptors (FGFRs) plays an impo

269 olid tumors harboring genetic alterations in fibroblast growth factor receptors (FGFRs) to determine

270 Fibroblast growth factors receptors (FGFRs) are thought

271 rogen receptor gene (ESR1), PIK3CA gene, and fibroblast growth factor receptor gene (FGFR2), among ot

272 In addition, we identified the fibroblast growth factor receptor gene, Fgfr2, as one oc

273 ell-based models of fibroblast growth factor/fibroblast growth factor receptor, glial cell line-deriv

274 mediated by the Forkhead TFs regulating the fibroblast growth factor receptor Heartless (Htl) and th

275 Furthermore, inactivation of fibroblast growth factor receptor in PyVmT-N-cadherin ce

276 domain, FGF23-21c was still able to activate fibroblast growth factor receptors in the presence of al

277 After injury and prolonged fibroblast growth factor receptor inhibition to arrest c

278 sensitivity to phosphoinositide 3-kinase and fibroblast growth factor receptor inhibition.

279 alpha), a key docking protein that transmits fibroblast growth factor receptor intracellular signalin

280 bited the highest kinase selectivity against fibroblast growth factor receptor kinase, platelet-deriv

281 se schistosome neoblast-like cells express a fibroblast growth factor receptor orthologue.

282 og; OSX, osterix transcription factor; FGFR, fibroblast growth factor receptor; PMN, polymorphonuclea

283 In vitro binding assays with recombinant fibroblast growth factor receptor protein revealed that

284 in unanswered, such as the identification of fibroblast growth factor receptor responsible for glucos

285 s differential responses to EGF receptor vs. fibroblast growth factor receptor signaling as well as t

286 Lastly, we show that fibroblast growth factor receptor signaling likely media

287 tes the epidermal growth factor receptor and fibroblast growth factor receptor signaling pathways inv

288 ed lymphatic endothelial cells by activating fibroblast growth factor receptor signaling.

289 , a protein that moderates glycosylation and fibroblast growth factor receptor signaling.

290 tor cells present in the eye, independent of fibroblast growth factor receptor signaling.

291 As determined by fibroblast growth factor receptor substrate 2 (FRS2) pho

292 ing pathways through their interactions with fibroblast growth factor receptor substrate 2 (FRS2).

293 We report that the docking protein fibroblast growth factor receptor substrate 2 (FRS2alpha

294 ion of a pan-FGF receptor adaptor Frs2alpha (fibroblast growth factor receptor substrate 2 alpha) in

295 ching defects; however, ureteric deletion of fibroblast growth factor receptor substrate 2alpha (Frs2

296 t either the neurotrophic signaling effector fibroblast growth factor receptor substrate 2alpha or th

297 cular endothelial growth factor receptor and fibroblast growth factor receptor, to cetuximab has show

298 f a plasmid expressing the nucleus-targeting fibroblast growth factor receptor type 1 resulted in sig

299 as platelet-derived growth factor receptor, fibroblast growth factor receptor, VEGF-R1, and VEGF-R3,

300 tinib, a potent tyrosine-kinase inhibitor of fibroblast growth factor receptors, VEGF receptors, PDGF